A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a ...

I think we’re going to be a team that’s on the map right now…” Anderson was one of several players suggesting on Friday that the Canadiens are through the rebuilding phase. He took it a ...

Shares in Ironwood Pharma fell by a third after it revealed that the FDA is insisting on a new phase 3 trial of its short bowel syndrome therapy before it can consider approval. The outcome of its ...

The H20 was an AI accelerator GPU with deliberately reduced performance density (around 2.9 TFLOPS/mm² vs the H100’s 19.4) designed to meet earlier export thresholds. The latest regulatory ...

(Reuters) - The White House has reversed course on curbs on Nvidia's H20 chips after CEO Jensen Huang attended a Mar-a-Lago dinner last week, NPR reported on Wednesday, citing two sources with ...